Northern Trust Corp Acer Therapeutics Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.67 - $3.05 $214 - $976	-320 Reduced 1.42%	22,231 $16,000
Q3 2022 Nov 14, 2022	BUY	$1.28 - $1.6 $4,025 - $5,032	3,145 Added 16.21%	22,551 $31,000
Q2 2022 Aug 12, 2022	BUY	$1.19 - $3.04 $318 - $814	268 Added 1.4%	19,406 $24,000
Q1 2022 May 13, 2022	SELL	$1.98 - $2.98 $681 - $1,025	-344 Reduced 1.77%	19,138 $55,000
Q4 2021 Feb 08, 2022	BUY	$1.88 - $2.9 $5,305 - $8,183	2,822 Added 16.94%	19,482 $44,000
Q3 2021 Nov 15, 2021	SELL	$2.3 - $2.86 $6,927 - $8,614	-3,012 Reduced 15.31%	16,660 $43,000
Q2 2021 Aug 13, 2021	SELL	$2.52 - $3.18 $10,823 - $13,658	-4,295 Reduced 17.92%	19,672 $57,000
Q1 2021 May 12, 2021	SELL	$2.47 - $4.39 $8,351 - $14,842	-3,381 Reduced 12.36%	23,967 $75,000
Q4 2020 Feb 11, 2021	SELL	$2.34 - $2.99 $8,739 - $11,167	-3,735 Reduced 12.02%	27,348 $72,000
Q3 2020 Nov 16, 2020	BUY	$2.16 - $5.41 $1,758 - $4,403	814 Added 2.69%	31,083 $90,000
Q2 2020 Aug 14, 2020	SELL	$1.53 - $4.53 $54,904 - $162,559	-35,885 Reduced 54.24%	30,269 $103,000
Q1 2020 May 14, 2020	SELL	$1.18 - $5.86 $10,487 - $52,083	-8,888 Reduced 11.84%	66,154 $132,000
Q4 2019 Feb 14, 2020	SELL	$2.85 - $4.2 $4,993 - $7,358	-1,752 Reduced 2.28%	75,042 $301,000
Q3 2019 Nov 13, 2019	BUY	$1.95 - $3.93 $55,537 - $111,930	28,481 Added 58.95%	76,794 $246,000
Q2 2019 Aug 13, 2019	BUY	$3.45 - $26.86 $32,743 - $254,928	9,491 Added 24.45%	48,313 $188,000
Q1 2019 May 13, 2019	BUY	$20.4 - $25.15 $107,099 - $132,037	5,250 Added 15.64%	38,822 $944,000
Q4 2018 Feb 12, 2019	BUY	$16.55 - $30.22 $29,740 - $54,305	1,797 Added 5.66%	33,572 $676,000
Q3 2018 Nov 14, 2018	BUY	$18.0 - $32.83 $571,950 - $1.04 Million	31,775 New	31,775 $980,000

Others Institutions Holding ACER

# of Institutions

Shares Held

365

Call Options Held

Put Options Held

Burleson & Company, LLC

365
Shares

$0
0.0% of portfolio

View Full List

About Acer Therapeutics Inc.

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

More about ACER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account